TP53 and intestinal neoplasm: Previously, we showed that the missense-type p53 mutation in the intestinal tumor cells leads to a dramatic transcriptomic shift through an increase in promoter accessibility (11), and inflammatory pathways, including TNFα/NF-κB, are significantly activated in p53-mutant AKTPR270H cells (13).